Home / Market News / $ALB
benzinga Corporate Catalyst Impact 65/100 ● negative

Argus Research Maintains Buy on Albemarle, Lowers Price Target to $135

Oct 7, 2026, 12:35 PM UTC · Primary ticker $ALB

Argus Research has lowered its price target for Albemarle (ALB) from $230 to $135, while maintaining a 'Buy' rating. This significant price target reduction, despite the maintained 'Buy' rating, suggests a re-evaluation of the company's near-term valuation prospects by the analyst.

Argus Research analyst Alexandra Yates has significantly lowered the price target for Albemarle (ALB) from $230 to $135, a substantial reduction of over 40%. Despite this, the 'Buy' rating has been maintained. This action indicates that while the analyst still sees long-term value in Albemarle, the near-term outlook or valuation metrics have deteriorated considerably. This could be due to factors like falling lithium prices, increased competition, or revised growth projections. For traders, this presents a short-term negative signal, as a lower price target often precedes downward pressure on the stock, even with a 'Buy' rating. The key risk is further downside if other analysts follow suit or if the underlying reasons for the price target cut persist.

$ALB negative Price target lowered significantly
Source: benzinga
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.